{
  "paper_metadata": {
    "pmid": "38182630",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the V30M variant in the TTR gene, focusing on its clinical significance, penetrance data, and biomarker potential in ATTRv amyloidosis."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.149G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 29,
        "demographics": "Mean age 69 years, 37.9% female",
        "phenotype": "A-ATTR-V30M patients with neurological involvement"
      },
      "penetrance_data": {
        "total_carriers_observed": 31,
        "affected_count": 29,
        "unaffected_count": 2,
        "uncertain_count": null,
        "penetrance_percentage": 93.55,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 69,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neurological involvement, late disease onset",
          "evidence_sentence": "All but 4 A-ATTRv patients had neurological involvement, most of them with late disease onset (20 patients, 80.0%)."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 69,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Neurological involvement, late disease onset",
          "evidence_sentence": "All but 4 A-ATTRv patients had neurological involvement, most of them with late disease onset (20 patients, 80.0%)."
        }
      ],
      "functional_data": {
        "summary": "The V30M variant is associated with elevated NfL levels, indicating axonal damage.",
        "assays": [
          "ELISA for NfL levels"
        ]
      },
      "segregation_data": "The V30M variant segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study highlights the importance of early diagnosis and monitoring of disease progression in A-ATTRv.",
      "key_quotes": [
        "V30M (p.V50M) is the most common TTR variant and is associated with ATTR amyloidosis-related polyneuropathy.",
        "Median NfL levels were 116 pg/mL in A-ATTRv patients, significantly higher than in asymptomatic carriers."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "The extraction was straightforward as the paper focused on the V30M variant in TTR."
  }
}